New Key Statistics Module, Z-Score and F-Score
NAS:ALNY Key Ratios
Market Cap $ M | 18,260.95 |
Enterprise Value $ M | 17,202.82 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 10.02 |
Price/Free Cash Flow | 748.19 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1,828.00 |
EPS (TTM) $ | -3.56 |
Beneish M-Score | -2.46 |
10-y EBITDA Growth Rate % | -7.60 |
5-y EBITDA Growth Rate % | 19.50 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -55.08 |
EV-to-EBITDA | -79.91 |
PEG | -- |
Shares Outstanding M | 126.45 |
Net Margin (%) | -24.08 |
Operating Margin % | -15.43 |
Pre-tax Margin (%) | -23.71 |
Quick Ratio | 2.99 |
Current Ratio | 3.08 |
ROA % (ttm) | -12.22 |
ROE % (ttm) | -- |
ROIC % (ttm) | -27.26 |
Dividend Yield % | -- |
Altman Z-Score | 0.99 |
Piotroski F-Score | 5.00 |
Positive ROA | N |
Positive CFROA | Y |
Higher ROA y-y | Y |
Cash flow > Earnings | Y |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | Y |
ALNY Number of Guru Trades
ALNY Volume of Guru Trades
Gurus Latest Trades with NAS:ALNY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ALNY is held by these investors
Total 4
Alnylam Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ALNY
Total 0- 1